Terms: = Prostate cancer AND TSHR, hTSHR-I, 7253, ENSG00000165409, MGC75129, LGR3
3 results:
1. Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes.
Lindenberg MA; Retèl VP; van der Poel HG; Bandstra F; Wijburg C; van Harten WH
Sci Rep; 2022 May; 12(1):7658. PubMed ID: 35538174
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence of APC and PTEN Alterations in Urachal cancer.
Nagy N; Reis H; Hadaschik B; Niedworok C; Módos O; Szendrői A; Bíró K; Hager T; Herold T; Ablat J; Black PC; Okon K; Tolkach Y; Csizmarik A; Oláh C; Keresztes D; Bremmer F; Gaisa NT; Kriegsmann J; Kovalszky I; Kiss A; Tímár J; Szász MA; Rink M; Fisch M; Nyirády P; Szarvas T
Pathol Oncol Res; 2020 Oct; 26(4):2773-2781. PubMed ID: 32754865
[TBL] [Abstract] [Full Text] [Related]
3. Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.
Hart SN; Ellingson MS; Schahl K; Vedell PT; Carlson RE; Sinnwell JP; Barman P; Sicotte H; Eckel-Passow JE; Wang L; Kalari KR; Qin R; Kruisselbrink TM; Jimenez RE; Bryce AH; Tan W; Weinshilboum R; Wang L; Kohli M
BMJ Open; 2016 Apr; 6(4):e010332. PubMed ID: 27084275
[TBL] [Abstract] [Full Text] [Related]
